BioAtla, Inc.
BCAB
$0.356
-$0.0002-0.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -95.41% | 6.05% | |||
| Gross Profit | 95.41% | -6.05% | |||
| SG&A Expenses | -5.63% | 14.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.86% | 8.43% | |||
| Operating Income | -5.86% | -8.43% | |||
| Income Before Tax | -22.02% | -3.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -22.02% | -3.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.02% | -3.02% | |||
| EBIT | -5.86% | -8.43% | |||
| EBITDA | -6.32% | -8.83% | |||
| EPS Basic | -21.50% | 12.21% | |||
| Normalized Basic EPS | -21.52% | 12.17% | |||
| EPS Diluted | -21.50% | 12.21% | |||
| Normalized Diluted EPS | -21.52% | 12.17% | |||
| Average Basic Shares Outstanding | 0.44% | 17.31% | |||
| Average Diluted Shares Outstanding | 0.44% | 17.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||